NeuroBo Pharmaceuticals Enters Into Term Sheet With MThera Pharma to Out-license NB-01
- Wednesday, August 2, 2023, 7:02
- Finance
- Add a comment
BOSTON, Aug. 2, 2023 /PRNewswire/ — NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced that it has entered into a term sheet with MThera Pharma Co., Ltd. (MTHERA) which provides for the…
About the Author
adminasapcorp has written 41523 stories on this site.